305 related articles for article (PubMed ID: 17991923)
1. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
Sloan JA; Berk L; Roscoe J; Fisch MJ; Shaw EG; Wyatt G; Morrow GR; Dueck AC;
J Clin Oncol; 2007 Nov; 25(32):5070-7. PubMed ID: 17991923
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life and symptom management research sponsored by the National Cancer Institute.
Minasian LM; O'Mara AM; Reeve BB; Denicoff AM; Kelaghan J; Rowland JH; Trimble EL;
J Clin Oncol; 2007 Nov; 25(32):5128-32. PubMed ID: 17991932
[TBL] [Abstract][Full Text] [Related]
3. Current status of patient-reported outcomes in industry-sponsored oncology clinical trials and product labels.
Gondek K; Sagnier PP; Gilchrist K; Woolley JM
J Clin Oncol; 2007 Nov; 25(32):5087-93. PubMed ID: 17991926
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes assessment in cancer trials: taking stock, moving forward.
Lipscomb J; Reeve BB; Clauser SB; Abrams JS; Bruner DW; Burke LB; Denicoff AM; Ganz PA; Gondek K; Minasian LM; O'Mara AM; Revicki DA; Rock EP; Rowland JH; Sgambati M; Trimble EL
J Clin Oncol; 2007 Nov; 25(32):5133-40. PubMed ID: 17991933
[TBL] [Abstract][Full Text] [Related]
5. Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions.
Ganz PA; Gotay CC
J Clin Oncol; 2007 Nov; 25(32):5063-9. PubMed ID: 17991922
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making.
Clauser SB; Ganz PA; Lipscomb J; Reeve BB
J Clin Oncol; 2007 Nov; 25(32):5049-50. PubMed ID: 17991919
[No Abstract] [Full Text] [Related]
7. Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions.
Wagner LI; Wenzel L; Shaw E; Cella D
J Clin Oncol; 2007 Nov; 25(32):5058-62. PubMed ID: 17991921
[TBL] [Abstract][Full Text] [Related]
8. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative.
Garcia SF; Cella D; Clauser SB; Flynn KE; Lad T; Lai JS; Reeve BB; Smith AW; Stone AA; Weinfurt K
J Clin Oncol; 2007 Nov; 25(32):5106-12. PubMed ID: 17991929
[TBL] [Abstract][Full Text] [Related]
9. Lessons learned in the assessment of health-related quality of life: selected examples from the National Cancer Institute of Canada Clinical Trials Group.
Brundage M; Osoba D; Bezjak A; Tu D; Palmer M; Pater J;
J Clin Oncol; 2007 Nov; 25(32):5078-81. PubMed ID: 17991924
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes supporting anticancer product approvals.
Rock EP; Kennedy DL; Furness MH; Pierce WF; Pazdur R; Burke LB
J Clin Oncol; 2007 Nov; 25(32):5094-9. PubMed ID: 17991927
[TBL] [Abstract][Full Text] [Related]
11. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
[TBL] [Abstract][Full Text] [Related]
12. Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program.
Buchanan DR; O'Mara AM; Kelaghan JW; Minasian LM
J Clin Oncol; 2005 Jan; 23(3):591-8. PubMed ID: 15659506
[TBL] [Abstract][Full Text] [Related]
13. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
Wiklund I
Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life measurement in symptom management trials.
Ganz PA; Goodwin PJ
J Natl Cancer Inst Monogr; 2007; (37):47-52. PubMed ID: 17951231
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standards.
Cleeland CS; Sloan JA;
J Pain Symptom Manage; 2010 Jun; 39(6):1077-85. PubMed ID: 20538189
[TBL] [Abstract][Full Text] [Related]
16. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
17. International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience.
Bottomley A; Aaronson NK;
J Clin Oncol; 2007 Nov; 25(32):5082-6. PubMed ID: 17991925
[TBL] [Abstract][Full Text] [Related]
18. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
Willke RJ; Burke LB; Erickson P
Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
[TBL] [Abstract][Full Text] [Related]
19. Funding patient-reported outcomes in cancer clinical trials.
Moinpour CM; Denicoff AM; Bruner DW; Kornblith AB; Land SR; O'Mara A; Trimble E
J Clin Oncol; 2007 Nov; 25(32):5100-5. PubMed ID: 17991928
[TBL] [Abstract][Full Text] [Related]
20. Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials.
Buchanan DR; O'Mara AM; Kelaghan JW; Sgambati M; McCaskill-Stevens W; Minasian L
Cancer; 2007 Oct; 110(7):1621-8. PubMed ID: 17868120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
